FAQs on Testing for SARS-CoV-2 | FDA

FAQs on Testing for SARS-CoV-2 | FDA

July 2 Update: New Information on Testing for SARS-CoV-2

Thank you for your interest in the development of diagnostics for SARS-CoV-2.  The FDA recently: ADDED the following question and answer: What is the difference between surveillance, screening, and diagnostic testing for COVID-19 testing?

See Update to FAQs Questions? Email CDRH-EUA-Templates@fda.hhs.gov